These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36098960)

  • 1. Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis.
    Andersen JB; Sellebjerg F; Magyari M
    Eur J Neurol; 2023 Jan; 30(1):162-171. PubMed ID: 36098960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population.
    Andersen JB; Wandall-Holm MF; Magyari M
    Mult Scler Relat Disord; 2022 Mar; 59():103529. PubMed ID: 35091367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study.
    Ludvigsson JF; Lebwohl B; Ekbom A; Kiran RP; Green PH; Höijer J; Stephansson O
    Gastroenterology; 2017 Feb; 152(3):554-563.e9. PubMed ID: 27773807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal outcomes in women with Multiple Sclerosis - Influence of disease activity: A Danish nationwide cohort study.
    Andersen ML; Jølving LR; Iachina M; Anru PL; Stenager E; Knudsen T; Nørgård BM
    Mult Scler Relat Disord; 2024 May; 85():105549. PubMed ID: 38518505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Events Associated With Disease-Modifying Drugs for Multiple Sclerosis: A Multiregional Population-Based Study.
    Ng HS; Zhu F; Zhao Y; Yao S; Lu X; Ekuma O; Evans C; Fisk JD; Marrie RA; Tremlett H
    Neurology; 2024 Feb; 102(3):e208006. PubMed ID: 38181306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy Outcomes in Men and Women Treated With Teriflunomide. A Population-Based Nationwide Danish Register Study.
    Andersen JB; Moberg JY; Spelman T; Magyari M
    Front Immunol; 2018; 9():2706. PubMed ID: 30532753
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review.
    Lu E; Wang BW; Guimond C; Synnes A; Sadovnick D; Tremlett H
    Neurology; 2012 Sep; 79(11):1130-5. PubMed ID: 22933738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study.
    Friend S; Richman S; Bloomgren G; Cristiano LM; Wenten M
    BMC Neurol; 2016 Aug; 16(1):150. PubMed ID: 27552976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glatiramer acetate during early pregnancy: A prospective cohort study.
    Herbstritt S; Langer-Gould A; Rockhoff M; Haghikia A; Queisser-Wahrendorf A; Gold R; Hellwig K
    Mult Scler; 2016 May; 22(6):810-6. PubMed ID: 26754804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes.
    Scheller NM; Pasternak B; Mølgaard-Nielsen D; Svanström H; Hviid A
    N Engl J Med; 2017 Mar; 376(13):1223-1233. PubMed ID: 28355499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Fexofenadine Use During Pregnancy and Fetal Outcomes.
    Andersson NW; Torp-Pedersen C; Andersen JT
    JAMA Pediatr; 2020 Aug; 174(8):e201316. PubMed ID: 32478810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desloratadine Use During Pregnancy and Risk of Adverse Fetal Outcomes: A Nationwide Cohort Study.
    Andersson NW; Poulsen HE; Andersen JT
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1598-1605. PubMed ID: 32142963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
    Pecori C; Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Sturchio A; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; Mancardi GL; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP;
    BMC Neurol; 2014 May; 14():114. PubMed ID: 24884599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
    Pasternak B; Svanström H; Mølgaard-Nielsen D; Krause TG; Emborg HD; Melbye M; Hviid A
    JAMA; 2012 Jul; 308(2):165-74. PubMed ID: 22782418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.
    Portaccio E; Annovazzi P; Ghezzi A; Zaffaroni M; Moiola L; Martinelli V; Lanzillo R; Brescia Morra V; Rinaldi F; Gallo P; Tortorella C; Paolicelli D; Pozzilli C; De Giglio L; Cavalla P; Cocco E; Marrosu MG; Patti F; Solaro C; Bellantonio P; Uccelli A; Laroni A; Pastò L; Giannini M; Trojano M; Comi G; Amato MP;
    Neurology; 2018 Mar; 90(10):e823-e831. PubMed ID: 29438046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate.
    Kaplan S; Dragut CF; Ghimpeteanu A
    Curr Med Res Opin; 2024 May; 40(5):821-825. PubMed ID: 38577712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final analysis of 379 pregnancy outcomes after exposure to dimethyl fumarate in a prospective international registry.
    Hellwig K; Rog D; McGuigan C; Houtchens MK; Bruen DR; Mokliatchouk O; Branco F; Levin S; Everage N; Lin X
    Mult Scler; 2024 Feb; 30(2):209-215. PubMed ID: 38166480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project.
    Lopez-Leon S; Geissbühler Y; Sabidó M; Turkson M; Wahlich C; Morris JK
    J Neurol; 2020 Sep; 267(9):2721-2731. PubMed ID: 32444984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
    Giannini M; Portaccio E; Ghezzi A; Hakiki B; Pastò L; Razzolini L; Piscolla E; De Giglio L; Pozzilli C; Paolicelli D; Trojano M; Marrosu MG; Patti F; La Mantia L; Mancardi G; Solaro C; Totaro R; Tola MR; De Luca G; Lugaresi A; Moiola L; Martinelli V; Comi G; Amato MP
    BMC Neurol; 2012 Oct; 12():124. PubMed ID: 23088447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.
    Lu E; Dahlgren L; Sadovnick A; Sayao A; Synnes A; Tremlett H
    Mult Scler; 2012 Apr; 18(4):460-7. PubMed ID: 21914689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.